Transcriptional Targeting in Cancer Gene Therapy
AUTOR(ES)
Robson, Tracy
FONTE
Hindawi Publishing Corporation
RESUMO
Cancer gene therapy has been one of the most exciting areas of therapeutic research in the past decade. In this review, we discuss strategies to restrict transcription of transgenes to tumour cells. A range of promoters which are tissue-specific, tumour-specific, or inducible by exogenous agents are presented. Transcriptional targeting should prevent normal tissue toxicities associated with other cancer treatments, such as radiation and chemotherapy. In addition, the specificity of these strategies should provide improved targeting of metastatic tumours following systemic gene delivery. Rapid progress in the ability to specifically control transgenes will allow systemic gene delivery for cancer therapy to become a real possibility in the near future.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=323956Documentos Relacionados
- Targeting HSP90 for cancer therapy
- Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy
- Targeting the mTOR Signaling Network for Cancer Therapy
- Targeting Radiotherapy to Cancer by Gene Transfer
- Targeting of Drugs 5. Strategies for Oligonucleotide and Gene Delivery in Therapy